ARCHIVES

NTP Board Considers Modification Of Human Risk Statement, Adopts Plan For Chemical Selection

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

May 27, 2011

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

Susan Horwitz Succeeds Waun Ki Hong As AACR President

April 12, 2002

Broder To Leave In March; Sondik To Be Acting Director

January 27, 1995

Local Labs Not As Accurate As Central Testing For HER2

August 30, 2002

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006